HelixDesign-Antibody: A Scalable Production-Grade Platform for Antibody Design Built on HelixFold3
This provides a more efficient solution for antibody engineering in therapeutics and biomedical research, though it appears incremental as it builds on existing structure prediction models.
The researchers tackled the problem of time-consuming and resource-intensive antibody discovery by introducing HelixDesign-Antibody, a scalable platform built on HelixFold3 for high-throughput generation and evaluation of antibody sequences, which validated a scaling law showing that exploring larger sequence spaces increases the likelihood of finding optimal binders.
Antibody engineering is essential for developing therapeutics and advancing biomedical research. Traditional discovery methods often rely on time-consuming and resource-intensive experimental screening. To enhance and streamline this process, we introduce a production-grade, high-throughput platform built on HelixFold3, HelixDesign-Antibody, which utilizes the high-accuracy structure prediction model, HelixFold3. The platform facilitates the large-scale generation of antibody candidate sequences and evaluates their interaction with antigens. Integrated high-performance computing (HPC) support enables high-throughput screening, addressing challenges such as fragmented toolchains and high computational demands. Validation on multiple antigens showcases the platform's ability to generate diverse and high-quality antibodies, confirming a scaling law where exploring larger sequence spaces increases the likelihood of identifying optimal binders. This platform provides a seamless, accessible solution for large-scale antibody design and is available via the antibody design page of PaddleHelix platform.